Anzeige
Mehr »
Samstag, 19.09.2026 - Börsentäglich über 12.000 News
Breaking News: NurExone im Vollgas-Modus!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
SB

WKN: A411DW | ISIN: CA81752F1062 | Ticker-Symbol: PSH0
Tradegate
18.09.26 | 20:13
0,068 Euro
+5,26 % +0,003
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SERNOVA BIOTHERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
SERNOVA BIOTHERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0600,06913:04
0,0600,06918.09.

Aktuelle News zur SERNOVA BIOTHERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12.09.Sernova Biotherapeutics Inc: Sernova shareholder Sangha to vote "yes" in takeover69
11.09.Sernova shareholder backs Seraxis takeover proposal27
11.09.Dr. Steven S. Sangha: Steven Sangha Announces Voting and Support Agreement for Sernova Biotherapeutics Inc.'s Proposed Business Combination with Seraxis Holdings, Inc.1.209Toronto, Ontario--(Newsfile Corp. - September 11, 2026) - Steven Sangha announces he has entered into a voting and support agreement ("Voting Agreement") with Seraxis Holdings, Inc. ("Seraxis") in connection...
► Artikel lesen
10.09.Stocks in Play: Sernova Biotherapeutics45
08.09.Stocks in Play: Sernova Biotherapeutics Inc.31
08.09.Sernova Biotherapeutics And Seraxis Holdings Agree To Merge To Form BetaNova Biotherapeutics28
08.09.Sernova und Seraxis fusionieren zu BetaNova Biotherapeutics, einem Spezialisten für Diabetes-Zelltherapie68
08.09.Sernova and Seraxis agree to merge, form BetaNova Biotherapeutics21
SERNOVA BIOTHERAPEUTICS Aktie jetzt für 0€ handeln
17.06.Sernova Biotherapeutics Inc: Sernova receives FDA orphan drug designation for AIT86
17.06.Stocks in Play: Sernova Biotherapeutics Inc.67
17.06.Sernova Says FDA Grants Orphan Drug Designation For Autologous Islet Transplantation45
17.06.Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy794TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused...
► Artikel lesen
24.04.Sernova Biotherapeutics Inc: Sernova closes financings, issues units for debts66
23.04.Sernova Biotherapeutics: Sernova Biotherapeutics Announces Closing of Recently Approved Financings1.073Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - April 23, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSHO) (XETRA: PSHO) ("Sernova" or the "Company"), a leading...
► Artikel lesen
10.04.Sernova Biotherapeutics Inc: Sernova shareholders re-elect six directors at AGM78
09.04.Sernova Biotherapeutics: Sernova Biotherapeutics Announces Affirmative Voting Results from 2026 Annual General Meeting of Shareholders809Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - April 9, 2026) - Sernova Biotherapeutics Inc. (TSX: SVA) (OTC: SEOVF) (FSE: PSH0) ("Sernova" or the "Company"), a leading regenerative...
► Artikel lesen
24.03.Sernova Biotherapeutics Inc: Sernova closes $2.1-million private placement58
24.03.Stocks in Play: Sernova Biotherapeutics39
24.03.Sernova Biotherapeutics: Sernova Biotherapeutics Announces Close of Non-Brokered Private Placement Financing651Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - March 24, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC Pink: SEOVF) (FSE: PSH0) ("Sernova" or the "Company"), a leading regenerative...
► Artikel lesen
04.03.Sernova Biotherapeutics: Sernova Biotherapeutics Strengthens Balance Sheet with $7.1 Million in Financings Plus Net Retirement of a Cumulative $17 Million of Debt Subject to Shareholder Approval949Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - March 4, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSHO) ("Sernova" or the "Company"), a leading regenerative medicine...
► Artikel lesen
Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
3,2,18